1 A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

2 A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

3 Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole

4 Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison

5 What happens after complete withdrawal of therapy in patients with lupus nephritis

6 HIV and diarrhea in the era of HAART: 1998 New York State hospitalizations

7 Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

8 Telaprevir for previously untreated chronic hepatitis C virus infection

9 Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review

10 Hepatic candidiasis: an increasing problem in immunocompromised patients

11 Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy

12 Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens

13 Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

14 Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial

15 Vedolizumab as induction and maintenance therapy for ulcerative colitis

16 Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

17 Community-acquired bacterial meningitis in adults

18 Boceprevir for untreated chronic HCV genotype 1 infection

19 Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

20 Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

21 Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients

22 Hemophagocytic lymphohistiocytosis syndrome in Dengue hemorrhagic fever

23 Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up

24 Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis

25 Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients

26 Use of corticosteroids in treating infectious diseases

27 Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study

28 Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

29 Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial

30 Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome

31 diagnosis and control of polypharmacy in the elderly diagnóstico e controle da polifarmácia no idoso

32 Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens

33 Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia

34 Emergence of multidrug-resistant Salmonella typhi in rural southern India

35 Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

36 Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

37 Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

38 A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria

39 Effects of postmeal exercise on postprandial glucose excursions in people with type 2 diabetes treated with add-on hypoglycemic agents

40 Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients

41 Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study

42 Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions

43 An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens

44 Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis

45 Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients

46 Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

47 [Treatment of immune thrombocytopenia: a retrospective study of 40 patients]

48 Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies

49 Chronic hepatitis B

50 The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

51 Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

52 Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses

53 Sofosbuvir for previously untreated chronic hepatitis C infection

54 Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada

55 Lymphatic filariasis and onchocerciasis

56 Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice

57 A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin

58 Decontamination of fresh-cut broccoli with a water–assisted UV-C technology and its combination with peroxyacetic acid

59 Construction of Luminogen Exhibiting Multicolored Emission Switching through Combination of Twisted Conjugation Core and Donor-Acceptor Units.

60 Risk profiles of pork and poultry meat and risk ratings of various pathogen/product combinations.

61 Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.

62 A Saccharide Chemosensor Array Developed Based on an Indicator Displacement Assay Using a Combination of Commercially Available Reagents.

63 In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.

64 Pharmacological investigation of 'HIM-CHX': A herbal combination in the experimental muscle wasting condition.

65 Antioxidative effects of supplementing linseed oil-enriched diets with α-tocopherol, ascorbic acid, selenium, or their combination on carcass and meat quality in broilers.

66 Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies

67 Accelerated approval and expensive drugs - A challenging combination

68 Biological Characterization and Inhibition of Streptococcus pyogenes ZUH1 Causing Chronic Cystitis by Crocus sativus Methanol Extract, Bee Honey Alone or in Combination with Antibiotics: An In Vitro Study

69 Fused rings with N-oxide and -NH: good combination for high density and low sensitivity energetic materials.

70 efficacy of chlorhexidine and a riboflavin/UVA combination on fungal agents of keratitis.

71 Effects of Several Common Antifungal Drugs (Clotrimazole, Miconazole, Fluconazole) alone and in Combination with Amphotericin B on Candida Species Isolated from Chronic Candidal Vulvovaginitis

72 Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci.

73 Bacillomycin D and its combination with amphotericin B: Promising antifungal compounds with powerful antibiofilm activity and wound-healing potency

74 Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery

75 Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

76 In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

77 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

78 Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

79 In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran

80 In vitro activity and post-antibiotic effects of linezolid in combination with fosfomycin against clinical isolates of Staphylococcus aureus

81 Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d’Ivoire

82 Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations

83 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

84 Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations

85 In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae

86 In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

87 A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria

88 Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro

89 Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

90 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

91 Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

92 Lercanidipine/enalapril combination in the management of obesity-related hypertension

93 Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan

94 Current perspectives on combination therapy in the management of hypertension

95 Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

96 Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy

97 Azilsartan/chlorthalidone combination therapy for blood pressure control

98 Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial

99 Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination

100 A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

101 First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination

Keyword Connections

Journals

Research Groups

Bibliographies